Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer

Abstract

Background: The literature on prognostic survival associated with left-sided versus right-sided colon cancer reveals significant distinctions in clinical outcomes and treatment responses, influenced by a multitude of biological, pathological, and molecular factors. Literature Review: Further investigations, such as those by (Zovak & Mužina Mišić, 2018), have indicated that while overall and disease-free survival rates post-surgery for stages I-III do not significantly differ between right- and left-sided colon cancers, there is a notable divergence in chemotherapy responses for disseminated disease ((Zovak & Mužina Mišić, 2018)). This suggests that treatment strategies should be tailored based on tumor sidedness, particularly in advanced cases. (Bahl et al., 2020) reinforced the notion that left-sided colon cancer generally correlates with better long-term survival compared to right-sided tumors, emphasizing the importance of tumor location in treatment planning ((Bahl et al., 2020)). The systematic review conducted by further elucidated the correlation between specific biomarkers and tumor location, indicating that right-sided tumors often exhibit poorer survival outcomes due to distinct biological behaviors. Conclusion: In conclusion, the literature collectively indicates that tumor sidedness plays a crucial role in the prognosis and treatment of colon cancer, with left-sided tumors generally associated with better outcomes. However, the complexity of the relationship between sidedness and survival outcomes is evident, as various studies highlight the influence of confounding factors, molecular characteristics, and treatment responses. As such, a nuanced understanding of these dynamics is essential for optimizing treatment strategies and improving patient management in colorectal cancer.